Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
|
|
- Sydney Chase
- 5 years ago
- Views:
Transcription
1 FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating hormone levels on cycle day 3 to predict ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization using a flare-up protocol Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D. Hacettepe University, Faculty of Medicine, Department of Obstetrics and Gynecology, Ankara, Turkey Objective: To determine whether cycle day 3 serum FSH levels predict poor ovarian response and cycle cancellation in women undergoing controlled ovarian hyperstimulation (COH) for IVF. Design: Prospective case series. Setting: University hospital IVF program. Patient(s): The study includes outcomes of 637 initial cycles of M?. Intervention(s): Controlled ovarian hyperstimulation was undertaken with a short, flareup GnRH agonist and hmg protocol. The relation of cycle day 3 FSH levels with various cycle characteristics and outcomes was determined. Main Outcome Measure(s): The accuracy of cycle day 3 FSH levels in predicting poor ovarian response and cycle cancellation was evaluated. Receiver operating characteristic curves were constructed to determine the optimum cutoff value for the cycle day 3 serum FSH level that best predicted poor ovarian response and cycle cancellation. Result(s): A cycle day 3 serum FSH level 213 miu/ml (conversion factor to SI unit, 1.00) was associated with a high likelihood of poor ovarian response and cycle cancellation. The sensitivity, specificity, and positive likelihood ratio of an FSH level of 13 miu/ml in predicting cycle cancellation were 52%, 91%, and 6.04, respectively. Conclusion(s): Cycle day 3 FSH screening appears to be a fairly accurate predictor of poor ovarian response and cycle cancellation in women undergoing COH using a short, flare-up GnRH agonist and hmg protocol. (Fertil Steril@ 1997;68: by American Society for Reproductive Medicine.) Key Words: Controlled ovarian hyperstimulation, day 3 FSH level, cycle cancellation, poor ovarian response, flare-up protocol The advent of intracytoplasmic sperm injection largely has obviated male infertility as a successlimiting factor in assisted reproduction. However, poor ovarian response remains a major challenge to overcome. Advanced female age is associated with poor hormonal and follicular response to controlled ovarian hyperstimulation (COH), with fewer available oocytes for retrieval and fewer embryos for transfer. These factors collectively increase cycle Received June 3, 1996; revised and accepted May 23, *Reprint requests: Timur Giirgan, M.D., Hacettepe Universitesi Tip Fakuhsi, Kadin HastalikIari ve Dogum Ana Bilim Dali, Sihhiye 06100, Ankara, Turkey (FAX: ; e- mail: HDURAN@NEKJRON.ATO.ORG.TRh cancellation and decrease pregnancy rates (PRs) (1). Nevertheless, chronologic age does not always show a linear correlation with the so-called ovarian age. Whereas some young women respond poorly to COH, some older women demonstrate an adequate response. In view of this fact, other variables besides age have been sought to predict ovarian response to exogenous gonadotropins (2). Of these, the most widely used is assessment of ovarian reserve using cycle day 3 FSH levels. Assessment of cycle day 3 FSH levels fulfills the criteria for a good screening test in that it is easily measurable, minimally invasive, and inexpensive, and it has good predictive value (3). The aim of the current study was to assess the /97/$17.00 PI1 SOO (97)00246-X
2 value of cycle day 3 serum FSH levels in determining ovarian response to a flare-up GnRH agonist (GnRHa) protocol combined with exogenous gonadotropins in women undergoing COH for IVF. MATERIALS AND METHODS This study included 637 initial cycles of IVF performed from May 1991 to January Cycle day 3 FSH levels were measured using the Amerlex-M FSH RIA kit (Johnson & Johnson Clinical Diagnostics Ltd., Amersham, Buckinghamshire, United Kingdom) on the third day of a spontaneous cycle, within 3 months of the IVF cycle. The within-assay and between-assay coefficients of variation of the kit were 3.2% and 8.4%, respectively. None of the patients had received any hormonal medication during the preceding menstrual cycle. Superovulation was undertaken using a short, flare-up GnRH-a protocol combined with hmg. Buserelin acetate nasal spray (Suprefact; Hoechst AG, Frankfurt-Main, Germany) was initiated (100 pg four times per day) on the first day of a spontaneous menstrual bleed and continued until the administration of hcg. Human menopausal gonadotropin was commenced on cycle day 3, provided a baseline vaginal ultrasonographic (US) examination showed the absence of cystic ovarian structures >lo mm in diameter, with a starting dosage of 225 U daily for 4 days. The dosage of hmg was individualized according to daily serum E2 levels and follicular response as assessed with vaginal US. Human chorionic gonadotropin was administered when at least two follicles reached or exceeded a mean diameter of 18 mm, with an Ez level >500 pg/ml (conversion factor to SI unit, 3.671). Follicular aspiration for oocyte collection was performed with transvaginal US guidance 36 hours after the administration of hcg. Sperm samples were prepared by the standard swim-up technique. Standard laboratory procedures were used for the handling of gametes and embryos (4, 5). Minimal essential medium with Earle s salts and L-glutamine (GIBCO BRL, Life Technologies Ltd. Paisley, Strathclyde, United Kingdom) were used as the insemination and culture media. The female partner s serum in 10% to 15% concentrations was added to the medium for culture of embryos. Embryo transfer was performed 48 hours after oocyte collection if fertilization was present. A maximum of four embryos were transferred. The luteal phase was supported with injections of hcg, 1,500 U, on days 3,6, and 9 after ET. Pregnancy was diagnosed by serially rising serum P-hCG (Amerlite; Amersham International, Amerikastraat, The Neth- erlands) levels, and a clinical pregnancy was confirmed by US demonstration of one or more gestational sacs. Several IVF cycle characteristics were evaluated in relation to different cutoff points of cycle day 3 FSH levels. The capacity of a given FSH level to discriminate between adequate and poor ovarian response was determined with 2 x 2 contingency tables. Cycle cancellation was undertaken, with poor ovarian response defined as a serum E2 level ~500 pg/ml and fewer than two follicles measuring 218 mm in diameter. Receiver operating characteristic curves were constructed to determine the optimum cycle day 3 FSH level that best predicted poor E2 response and cycle cancellation. Likelihood ratios were calculated to determine the predictive accuracy of cycle day 3 FSH levels to presage poor ovarian response and cycle cancellation. All data were processed with the Statistical Program for Social Sciences (SPSS Inc., Chicago, IL) on an Apple Macintosh (Bilkom, Istanbul, Turkey) personal computer. One-way analysis of variance with the Tukey Honest Significant Difference post hoc test was used for analysis of the results. Data were expressed as means + SD. Statistical significance was accepted at a P level <0.05. Receiver operating characteristic curve analysis was performed by Medcalc (Medcalc Software, Mariakerke, Belgium) on an IBM-compatible personal computer (Condor Computers, Istanbul, Turkey). RESULTS Cycle characteristics in relation to various cutoff levels of cycle day 3 FSH levels are shown in Table 1. Estradiol levels on the day of hcg administration were significantly lower when day 3 FSH levels were >15 miu/ml (conversion factor to SI unit, 1.00). Further, E2 levels of women with day 3 FSH levels > 13 miu/ml were significantly lower than those of women with day 3 FSH levels <lo miu/ml. Similarly, the number of follicles >14 mm in diameter, the number of oocytes retrieved, and ovarian response showed a decreasing trend with increasing day 3 FSH levels. Cycle cancellation rates increased from 7.9% to 55.5% in women with day 3 FSH levels of <lo and >20 miu/ml, respectively. Fertilization rates did not differ between groups. The number of embryos available for transfer was significantly less when day 3 FSH levels exceeded 15 miu/ml. The clinical PR per initiated cycle was 19.3% when the day 3 FSH level was ~10 miu/ml. This figure decreased to 6.7% when the FSH level was >15 miu/ml. No pregnancies were achieved when the FSH level was >20 miu/ml. 484 Giirgan et al. Cycle day 3 FSH levels and response to COH Fertility and Sterility@
3 Table 1 In Vitro Fertilization Cycle Characteristics in Relation to Cycle Day 3 FSH Levels* Group 1 Group 2 Group 3 Group 4 Group 5 No. of cycles Age Wt k k 3.5 E2 level on the day of hcg adminstration (pg/ml)$ l/qi 1, , , ? 342 No. of follicles >14 rnrn$lln 4.2 k ? ? 0.9 Poor responsell** 56 (11.4) 10 (14.9) 4 (20) 23 (56) 12 (66.6) Cycle cancellation ** 39 (7.9) 7 (10.4) 3 (15) 19 (46.7) 10 (55.5) No. of occytes$tt t Fertilization rate (%I$ k k t No. of embryos transferred r k k 1.3 Clinical pregnancy per cycle (%)I/ * FSH levels (in miu/ml; conversion factor to SI unit, 1.00): group 1, 0 to 9; group 2, 10 to 12.9; group 3, 13 to 14.9; group 4, 15 to 19.9; and group 5, 220. t Groups 3 and 4 are significantly different from Groups 1, 2, and 5. $ Values are means 2 SD. Q Conversion factor to SI unit, Groups 4 and 5 are significantly different from Groups 1, 2, and 3. 1 Group 3 is significantly different from Group 1. ** Values in parentheses are percentages. tt Groups 3,4, and 5 are significantly different from Groups 1 and 2. Regression analysis showed that age, day 3 FSH level, and etiology of infertility had significant association with both cycle cancellation rates and low E2 levels. Logistic regression analysis, however, showed that day 3 FSH level was the only independent variable that had a statistically significant association with low Ez levels on the day of hcg administration and subsequent cycle cancellation (log likelihood = 260.5, significance of log likelihood ratio (LR) < 0.001). Receiver operating characteristic curves were constructed to determine the optimum age of the woman and the day 3 FSH level at which cycle cancellation was predicted best (Figs. 1 and 2). The day 3 FSH level that predicted poor hormonal response and cy- cle cancellation most accurately was >13 miu/ml. Likewise, the age of the woman that predicted these outcomes most accurately was >36 years (Table 2). DISCUSSION This study demonstrates that FSH levels measured on the third day of a spontaneous menstrual cycle are predictive of poor hormonal response and subsequent cycle cancellation in women undergoing COH for IVF with a short, flare-up GnRH-a and hmg protocol. The likelihood of poor hormonal response, defined as an E2 level <500 pg/ml on the day of hcg administration, and the likelihood of cycle cancellation were 2.89 and 6.04, respectively, when False-positive fraction Figure 1 Receiver operating curve for cycle day 3 FSH level in predicting cycle cancellation; cycle day 3 FSH level of >13 miu/ ml (conversion factor to SI unit, 1.00) best predicted cycle cancellation. Figure 2 Receiver operating curve for cycle day 3 FSH level in predicting poor Ez response; cycle day 3 FSH level of >13 miu/ ml (conversion factor to SI unit, 1.00) best predicted poor E, response. Vol. 68, No. 3, September 1997 Giirgan et al. Cycle day 3 FSH levels and response to COH 485
4 Table 2 Prediction of Cycle Cancellation and Ez Level <500 pg/ml on the Day of HCG Administration When Age >36 Years and Cycle Day 3 FSH >13 miu/ml Sensitivity Specificity Positive Positive Negative likelihood ratio predictive value predictive value Prediction of cycle cancellation Age >36 y FSH >13 III/L Prediction of Ez level <500 pg/ml on the day of hcg administration Age >36 y FSH >13 miu/ml * Conversion factor to SI unit: Ez, 3.671; FSH, day 3 FSH levels reached or exceeded 13 miu/ml. Age alone appeared to be a less accurate predictor of ovarian response to COH than 3 day FSH levels. Ovarian response to hmg previously was shown to be predicted fairly accurately with day 3 FSH levels. Muasher et al. (6) investigated the predictive value of cycle day 3 gonadotropins in determining the extent of ovarian response to COH for IVF using FSH and hmg. Their study demonstrated the value of cycle day 3 serum gonadotropin measurements in distinguishing between different responders to exogenous gonadotropins. In addition to predicting poor ovarian response, increasing FSH levels were associated with decreasing PRs. Similar conclusions were reached in a study by Toner et al (21, who analyzed 1,478 consecutive IVF cycles using hmg and/or FSH for COH. These authors concluded that FSH level is a better predictor of IVF outcome than chronologic age. Serum cycle day 3 FSH screening also has been reported to be a sensitive indicator of ovarian responsiveness to stimulation with hmg after pituitary suppression with a GnRH-a (buserelin) initiated in the luteal phase (7). Whether the predictive value of serum day 3 FSH screening is retained in a short, flareup GnRH-a protocol is unknown. Because a GnRH-a in a short, flare-up protocol usually is advocated in poor responders, the relation between certain cycle outcomes and day 3 serum FSH screening becomes more important (8). Padilla et al. (9) investigated the prognostic value of early FSH and LH levels and serum Ez response on IVF outcome in 100 cycles, using a flare-up GnRH-a protocol. They concluded that, although not statistically significant, an early serum FSH level >20 miu/ml was associated with a lower clinical PR. They also stated that early Ez response to leuprolide acetate probably was the best prognostic indicator of IVF outcome. Our results demonstrate that the day 3 FSH level is the only independent variable to predict a low Ez level on the day of hcg administration and subsequent cycle cancellation in a flare-up GnRH-a and hmg protocol. Using receiver operating characteristic curves, the day 3 FSH level that predicted poor hormonal response and cycle cancellation most accurately was 13 miu/ml. It is unknown whether routine screening of all IVF candidates with day 3 serum FSH levels is cost-effective. Although diminished ovarian reserve appears to be relatively rare in a young patient with two ovaries, screening regardless of age is recommended when the woman has a single ovary or a history of ovarian endometriosis or multiple ovarian operations (10). Routine screening may identify the occasional young woman with diminished ovarian reserve. Our results may be criticized because they are constructed on a single day 3 FSH level. However, Scott et al. (11) performed a paired analysis of high and low FSH cycles in women undergoing IVF and showed no differences in stimulation quality, the number of oocytes retrieved, or fertilization rates. All patients behaved as low responders in both cycles. In conclusion, this study demonstrates the accuracy of day 3 serum FSH screening in predicting poor ovarian response and subsequent cycle cancellation. A day 3 serum FSH cutoff level > 13 miu/ml is associated with a high likelihood of cycle cancellation when a short, flare-up GnRH-a protocol combined with hmg is used for COH REFERENCES Scott R, Toner J, Muasher S, Oehninger S, Robinson S, Rosenwaks Z. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51: Toner J, Philput C, Jones J, Muasher S. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55: Scott R, Hofmann G. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11. Dandekar P, Quigley M. Laboratory setup for human in vitro fertilization. Fertil Steril 1984; 42:1-11. The American Fertility Society. Guidelines for in vitro fertilization, gamete intrafallopian transfer and related procedures. Fertil Steril 1991;56: Giirgan et al. Cycle day 3 FSH levels and response to COH Fertility and Sterility@
5 6. Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, et al. The value of basal and stimulated gonadotropin levels in prediction of stimulated response in in-vitro fertilization outcome. Fertil Steril 1988;50: Cahill D, Wardle P, Ford W, Hull M. Relative influence of serum follicle stimulating hormone, age, and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994; 101: Muasher S. Controversies in assisted reproduction: treatment of low responders. J Assist Reprod Genet 1993;lO: Padilla SL, Bayati J, Garcia JE. Prognostic value of the early serum e&radio1 response to leuprolide acetate in in vitro fertilization. Fertil Ski1 1990;53: Khalifa E, Toner J, Muasher S, Acosta A. Significance of basal follicle stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil Steril 1992;57: Scott R, Hofmann G, Oehninger S, Muasher S. Intercycle variability of day 3 follicle stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54: Vol. 68, No. 3, September 1997 Giirgan et al. Cycle day 3 FSH levels and response to COH 487
in vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationIVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1
CLINICAL ASSISTED REPRODUCTION IVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1 A. LASS, 2,3 A. GERRARD, 2 N. ABUSHEIKHA, 2 F. AKAGBOSU, 2 and P. BRINSDEN 2 Submitted: April
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationAge and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome
British Journal of Obstetrics and Gynaecology January 1998, Vol. 105, pp. 107-1 12 Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome Khaldoun Sharif Lecturer, Manal
More informationGn-RH Agonist Challenge Test for Predicting Ovarian Reserve in Short Protocol Cycles
J Obstet Gynecol lnd Vol. 54, No.1: January/February 2004 Pg 51-55 Gn-RH Agonist Challenge Test for Predicting Ovarian Reserve in Short Protocol Cycles Ocal Pelin, Cepni Ismail, Akbas Hande, Idil Mehmet,
More informationSignificance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization*
FERTILITY AND STERILITY Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationIVF treatment should not be postponed for patients with high basal FSH concentrations
Reproductive BioMedicine Online (2010) 21, 631 635 www.sciencedirect.com www.rbmonline.com SHORT COMMUNICATION IVF treatment should not be postponed for patients with high basal FSH concentrations Ettie
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationBulent Urman, M.D.* Margo R. Fluker, M.D. Basil Ho Yuen, M.B., Ch.B.t
FERTILITY AND STERILITY Copyright c 1992 The American Fertility Society Vol. 57, No.6, June 1992 Printed on acid-free paper in U.S.A. The outcome of in vitro fertilization and embryo transfer in women
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationEstradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27
More informationOvulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*
FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance
More informationIntercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization*
FERTILITY AND STERILITY Copyright C> 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Inter variability of day 3 follicle-stimulating hormone levels and its effect on stimulation
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationProspective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Prospective study of short and ultrashort regimens of gonadotropinreleasing hormone agonist in
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 82, NO. 4, OCTOBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION Prognostic
More informationRafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant
More informationEvaluation of basal estradiol levels in assisted reproductive technology cycles
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Evaluation of basal
More informationJinan Bekir, M.D. Amma Kyei-Mensah, M.D. Seang-Lin Tan, M.D.
FERTILITY AND STERILITY Copyright ~ 1995 American Society for Reproductive Mediciue Vol. 64, No.4, October 1995 Printed on acid-free paper in U. S. A. Administration of progestogens to hasten pituitary
More informationPremature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles
Arch Gynecol Obstet (2010) 281:747 752 DOI 10.1007/s00404-009-1248-0 REPRODUCTIVE MEDICINE Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles Esra
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More information(BMI)=18.0~24.9 kg/m 2 ;
33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationArticle Prediction of pituitary down-regulation by evaluation of endometrial thickness in an IVF programme
RBMOnline - Vol 8. No 5. 2004 595-599 Reproductive BioMedicine Online; www.rbmonline.com/article/1065 on web 17 March 2004 Article Prediction of pituitary down-regulation by evaluation of endometrial thickness
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationGnRHa stop protocol versus long protocol in poor responder IVF patients
Iranian Journal of Reproductive Medicine Vol.6. No.1. pp: 33-37, Winter 2008 GnRHa stop protocol versus long protocol in poor responder IVF patients Ensieh Shahrokh Tehrani nejad M.D., Behnaz Attar Shakeri
More informationProgramming in vitro fertilization for a 5- or 3-day week
Ass~st.d.reproductive tec"no'ogy FERTILITY AND STERILITY Copyright I[J 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Programming in vitro fertilization for a 5- or 3-day week
More informationCorrelation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome
Original Article Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome Sudha Prasad 1*, Teena Gupta 1, Aabha Divya 2 1- IVF and Reproductive Biology Centre, Department of
More informationAssisted Reproduction Unit, American Hospital of Istanbul, Istanbul, Turkey
FERTILITY AND STERILITY VOL. 72, NO. 6, DECEMBER 1999 Copyright 1999 American Society for Reproductive Medicine ublished by Elsevier Science Inc. rinted on acid-free paper in U.S.A. ROGESTERONE Elevated
More informationLOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS
LOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS Salem H. H. '; Nassar A. M.,&l ; Askalany N. A. ', Kassem K. 1&4 Department of Obstetrics and Gynecology Al Azhar
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationOriginal Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer
Int J Clin Exp Med 2015;8(7):11327-11331 www.ijcem.com /ISSN:1940-5901/IJCEM0008838 Original Article Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationChanges in measured endometrial thickness predict in vitro fertilization success
Changes in measured endometrial thickness predict in vitro fertilization success Grant D. E. McWilliams, D.O., a and John L. Frattarelli, M.D. b a Tripler Army Medical Center, Honolulu, Hawaii; and b Reproductive
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationBest practices of ASRM and ESHRE
Best practices of ASRM and ESHRE Late submission Cortina d Ampezzo, Italy 1-3 March 2012 A joint meeting between the American Society for Reproductive Medicine and the European Society of Human Reproduction
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationPrognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK
Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK Obstetrics Gynecology and Reproductive Medicine Department Bichat
More informationSupraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles
Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationProspective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in
More informationAnalysis of factors affecting embryo implantation
Analysis of factors affecting embryo implantation Andrew L.Speirst, H.W.G.Baker and Nusratudin Abdullah The Royal Women's Hospital, Melbourne, Australia ITo whom correspondence should be addressed Introduction
More informationA prospective randomized study comparing aspiration only with aspiration and flushing for transvaginal ultrasound-directed oocyte recovery
FERTILITY AND STERILITY Vol. 58, No.2, August 1992 Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. A prospective randomized study comparing aspiration only with aspiration
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationSerum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip
J MEDICINE 2013; 14 : 52-56 Serum Estradiol Level as a Predictor of Ovarian Response and Pregnancy Outcome During Controlled Ovarian Hyperstimulation in Women from Gaza Strip MAGED M. YASSIN, 1 MOHAMMED
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationEffect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer cycles*
FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Effect of baseline ovarian cysts on in vitro fertilization and gamete intrafallopian transfer
More informationREstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization
REstradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? FTThe Journal of Reproductive
More informationOvarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization
Ovarian age-based stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization Norbert Gleicher, M.D., and David Barad, M.D. Center for Human
More informationIranian Journal of Reproductive Medicine Vol. 2. No.1 pp 29-33, 2004
Efficacy of Low Dose, Long-acting Gonadotropin Releasing Hormone Analogues (GnRH-a) Compared with Daily Injections of Short-acting GnRH-a in ART Cycles Robabeh Taheripanah M.D. 1, Mohammad A. Karimzadeh
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Infertility Injectables Table of Contents Coverage Policy... 1 General Background...16 Coding/Billing Information...20 References...20 Effective Date...
More informationUse of clomiphene to prevent premature luteinizing hormone surge during controlled ovarian hyper stimulation
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Bhandari S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jun;5(6):1944-1948 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationFollicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation
Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/22797
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationImpact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer
CLINICAL ASSISTED REPRODUCTION Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer LUBNA PAL,1,3 JAN L. SHIFREN,2 KEITH B. ISAACSON,1 YuCHIAO CHANG,2 LUCY
More informationGNRH ANTAGONIST/LETROZOLE VERSUS MICRODOSE GNRH AGONIST FLARE PROTOCOL IN POOR RESPONDERS UNDERGOING IN VITRO FERTILIZATION
ORIGINAL ARTICLE GNRH ANTAGONIST/LETROZOLE VERSUS MICRODOSE GNRH AGONIST FLARE PROTOCOL IN POOR RESPONDERS UNDERGOING IN VITRO FERTILIZATION Robab Davar 1, Homa Oskouian 2 *, Shahnaz Ahmadi 2, Razieh Dehghani
More informationThe outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology
Human Reproduction vol.14 no.1 pp.167 171, 1999 The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Lawrence Engmann 1,2,5, Noreen Maconochie
More informationDepartment of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Printed on acid-free paper in U.S.A. The effect of baseline complex ovarian cysts on in vitro fertilization outcome*t Elizabeth A.
More informationthat induce morphologic (4, 5) and biochemical (6) endometrial alterations relevant to uterine receptivity.
FERTILITY AND STERILITY VOL. 70, NO. 2, AUGUST 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. 12 Increasing uterine
More informationAccuracy of ovarian reserve tests
Human Reproduction vol. no. pp.-6, Accuracy of ovarian reserve tests BUlent Gülekli ' ', Yesim Bulbul, Ata Onvural, Kutsal Yorukoglu, Cemal Posaci, Namik Demir and Oktay Erten,, To whom correspondence
More informationA Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist
1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang
More informationGonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome
FERTILITY AND STERILITY Copyright e 1993 The American Fertility Society Vol. 59, No.3, March 1993 Printed on acid-free paper in U.S.A. Gonadotropin-releasing hormone agonist reduces the miscarriage rate
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationThe influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients
Human Reproduction Vol.17, No.5 pp. 1207 1211, 2002 The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients Sheila Loh
More informationThe association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age
Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G
More informationLiyan Duan 1, Shihua Bao 1, Kunming Li 1, Xiaoming Teng 1, Ling Hong 1 and Xiaoyu Zhao 2. Abstract. Introduction
doi:10.1111/jog.13305 J. Obstet. Gynaecol. Res. Vol. 43, No. 6: 1037 1042, June 2017 Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of
More informationVaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer
Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization embryo transfer Mohamed F. Mitwally, M.D., H.C.L.D., a Michael P. Diamond,
More informationIVF Patient Information
What is IVF? IVF (In Vitro Fertilisation) is a treatment by which fertilisation of eggs by sperm takes place outside the body in a dish in an IVF laboratory. An ovary has a pool of immature eggs. In a
More informationThree-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age
FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Three-dimensional
More informationHerjan Coelingh Bennink, M.D.:j: Andre Van Steirteghem, M.D., Ph.D.* Paul Devroey, M.D., Ph.D.*
J FERTILITY AND STERILITY@ Copyright 't; 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing
More informationOriginal Article. Downloaded from
Original Article Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection Aysen Boza 1, Erbil
More informationMilan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,
FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol
More informationFactors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2015;42(2):67-71 Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles Ju Hee Park
More informationCigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test*
FERTILITY AND STERILITY Copyright @ 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationEffects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment
FERTILITY AND STERILITY VOL. 74, NO. 5, NOVEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effects of functional
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationA luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates
A luteal estradiol protocol for anticipated poor-responder patients may improve delivery rates Micah J. Hill, D.O., a Grant D. E. McWilliams, D.O., b Kathleen A. Miller, B.S., c Richard T. Scott, Jr, M.D.,
More informationMedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar
More informationLuteal phase rescue after GnRHa triggering Progesterone and Estradiol
Luteal phase rescue after GnRHa triggering Progesterone and Estradiol L. Engmann University of Connecticut Disclaimer Fertility Speaker Bureau Merck Pharmaceuticals Introduction GnRH agonist is effective
More informationArticle Evaluation of functional ovarian reserve in 60 patients
RBMOnline - Vol 7. No 2. 200 204 Reproductive BioMedicine Online; www.rbmonline.com/article/846 on web 12 June 2003 Article Evaluation of functional ovarian reserve in 60 patients Dr Giuseppe Loverro Giuseppe
More information(1.,, ) (2.,,, )
33 11 Vol.33 No.11 2013 11 Nov. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.11.0749 E-mail: randc_journal@163.com IVF-ET 1 2 1 1 1 1 1 (1. 510150) (2. 510150) : (COH) (premature
More information